Technical Description
The present invention relates to a biophotonic nanocontrast comprising of lipid nanoparticles encapsulating red emissive indocyanine green (ICG) aggregates through nanoprecipitation method.
Problems Addressed
- Complicated Methods
- Inefficient Existing System
- Low Compatibility
- Expensive
- Non-Targeted Binding
Tech Features
- High Storage
- Stability
- Targets Cancer Cells
- 87% ICG Molecules Releases
- Biocompatibility
- High Absorption
- Feasible & Inexpensive
Target Audience
- Healthcare & Medical Sector
- Diagnostic Industry
- Pharmaceutical Industry
- Research & Development
Tech ID: P26-1524 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
